Therapeutic Hypothermia After Cardiac Arrest

John McPherson

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

Intra-Aortic Balloon Pump: New Insights

David Baran

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?

Canadian Collaborative Research Network

N. Singh

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

University of Minnesota

D. Yannopoulos

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

ESC 2024 Insights: Short- and Long-Term Effects of Beta-blockers on …

ESC 2024 Insights

P. Leissner

Cardiac Surgery Case: Post Cardiotomy Shock Requiring Mechanical Cir…

The 10th Annual Western New England Acute Cardiology Conference

K. Wanamaker

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan